Italia markets closed

ILMN Sep 2024 240.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,60000,0000 (0,00%)
In data: 09:50AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente1,6000
Aperto1,5500
Denaro1,1000
Lettera3,4000
Prezzo d'esercizio240,00
Scadenza2024-09-20
Min-Max giorno1,5500 - 1,6000
Contratto - Min-MaxN/D
Volume6
Open Interest11
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera